[Exclusive offer for ZP Club member]

[Notice: ZP Club product only deliver to account default company address. Please do not change the account company address]

The Panbio™ COVID-19/Flu A&B Panel (Nasal) is an in vitro diagnostic rapid test for the qualitative detection of nucleocapsid proteins SARSCoV-2 and nucleoproteins Influenza A&B antigens (Ag) in human nasal mid turbinate (NMT) swab specimens from symptomatic individuals, who meet COVID-19 and/or Influenza clinical and/or epidemiological criteria. Panbio™ COVID-19/Flu A&B Panel (Nasal) is intended for use by trained professionals in a laboratory and near-patient setting as an aid in the diagnosis of SARS-CoV-2 and Influenza infection. It is not intended for self testing. This test is not automated. The test provides preliminary test results. Negative results don’t preclude SARS-CoV-2 and Influenza A&B infection and they cannot be used as the sole basis for treatment or other management decisions. Negative results should combine with clinical observations, patient history, and epidemiological information.

Functionality
This test is designed for use by professionals in both laboratories (including laboratory technicians) and near patient settings, such as:
Clinician’s office and clinics. Suitable personnel shall have an appropriate level of training and experience in a range of analytical techniques, including device and specimen preparation, reagent preparation, the running and interpretation of specimens, management of all supplies and waste disposal as per local regulations and generation of reports.